Low cardiac output states after open heart surgery. Comparative hemodynamic effects of dobutamine, dopamine, and norepinephrine plus phentolamine. 1981

R Gray, and P K Shah, and B Singh, and C Conklin, and J M Matloff

The hemodynamic effects of dobutamine, dopamine, and a combination of norepinephrine-phentolamine were compared in nine patients with low cardiac output state after open heart surgery. Using a Latin square design for drug sequence, each patient was given each drug at three levels by continuous intravenous infusion. For dobutamine and dopamine the doses were 2.5, 5.0 and 10.0 microgram/kg/min; for norepinephrine, 0.02, 0.05 and 0.10 microgram/kg/min with phentolamine in the ratio of 1 (norepinephrine) to 2.5 (phentolamine). Dobutamine and dopamine both produced an increase in heart rate, mean arterial pressure, cardiac index, and stroke volume index. Both drugs reduced total pulmonary and systemic vascular resistance in the dose range of 5.0 to 10.0 microgram/kg/min. When the maximum tolerated doses were compared, the drugs equally increased cardiac index and stroke volume index, but dopamine did so at a smaller dose than dobutamine. At equivalent doses, dobutamine tended to produce less tachycardia and vasoconstriction than dopamine. The norepinephrine-phentolamine combination resulted in increases in both systemic arterial pressure and vascular resistance with no significant increase in cardiac index. Its unique feature was its predictable vasopressor response with absence of chronotropic effects and ventricular irritability.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009638 Norepinephrine Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic. Levarterenol,Levonorepinephrine,Noradrenaline,Arterenol,Levonor,Levophed,Levophed Bitartrate,Noradrenaline Bitartrate,Noradrénaline tartrate renaudin,Norepinephrin d-Tartrate (1:1),Norepinephrine Bitartrate,Norepinephrine Hydrochloride,Norepinephrine Hydrochloride, (+)-Isomer,Norepinephrine Hydrochloride, (+,-)-Isomer,Norepinephrine d-Tartrate (1:1),Norepinephrine l-Tartrate (1:1),Norepinephrine l-Tartrate (1:1), (+,-)-Isomer,Norepinephrine l-Tartrate (1:1), Monohydrate,Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer,Norepinephrine l-Tartrate (1:2),Norepinephrine l-Tartrate, (+)-Isomer,Norepinephrine, (+)-Isomer,Norepinephrine, (+,-)-Isomer
D010646 Phentolamine A nonselective alpha-adrenergic antagonist. It is used in the treatment of hypertension and hypertensive emergencies, pheochromocytoma, vasospasm of RAYNAUD DISEASE and frostbite, clonidine withdrawal syndrome, impotence, and peripheral vascular disease. Fentolamin,Phentolamine Mesilate,Phentolamine Mesylate,Phentolamine Methanesulfonate,Phentolamine Mono-hydrochloride,Regitine,Regityn,Rogitine,Z-Max,Mesilate, Phentolamine,Mesylate, Phentolamine,Methanesulfonate, Phentolamine,Mono-hydrochloride, Phentolamine,Phentolamine Mono hydrochloride
D002303 Cardiac Output, Low A state of subnormal or depressed cardiac output at rest or during stress. It is a characteristic of CARDIOVASCULAR DISEASES, including congenital, valvular, rheumatic, hypertensive, coronary, and cardiomyopathic. The serious form of low cardiac output is characterized by marked reduction in STROKE VOLUME, and systemic vasoconstriction resulting in cold, pale, and sometimes cyanotic extremities. Low Cardiac Output,Low Cardiac Output Syndrome,Output, Low Cardiac
D002395 Catecholamines A general class of ortho-dihydroxyphenylalkylamines derived from TYROSINE. Catecholamine,Sympathin,Sympathins
D004280 Dobutamine A catecholamine derivative with specificity for BETA-1 ADRENERGIC RECEPTORS. It is commonly used as a cardiotonic agent after CARDIAC SURGERY and during DOBUTAMINE STRESS ECHOCARDIOGRAPHY. Dobucor,Dobuject,Dobutamin Fresenius,Dobutamin Hexal,Dobutamin Solvay,Dobutamin-ratiopharm,Dobutamina Inibsa,Dobutamina Rovi,Dobutamine (+)-Isomer,Dobutamine Hydrobromide,Dobutamine Hydrochloride,Dobutamine Lactobionate,Dobutamine Phosphate (1:1) Salt, (-)-Isomer,Dobutamine Tartrate,Dobutamine Tartrate (1:1), (R-(R*,R*))-Isomer,Dobutamine Tartrate (1:1), (S-(R*,R*))-Isomer,Dobutamine, (-)-Isomer,Dobutamine, Phosphate (1:1) Salt (+)-Isomer,Dobutrex,Lilly 81929,Oxiken,Posiject,Dobutamin ratiopharm,Hydrobromide, Dobutamine,Hydrochloride, Dobutamine,Lactobionate, Dobutamine,Tartrate, Dobutamine
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005260 Female Females

Related Publications

R Gray, and P K Shah, and B Singh, and C Conklin, and J M Matloff
June 1995, Lijecnicki vjesnik,
R Gray, and P K Shah, and B Singh, and C Conklin, and J M Matloff
March 1980, [Zasshi] [Journal]. Nihon Kyobu Geka Gakkai,
R Gray, and P K Shah, and B Singh, and C Conklin, and J M Matloff
February 1986, International journal of clinical pharmacology, therapy, and toxicology,
R Gray, and P K Shah, and B Singh, and C Conklin, and J M Matloff
April 2006, Revista espanola de cardiologia,
R Gray, and P K Shah, and B Singh, and C Conklin, and J M Matloff
August 1984, The Annals of thoracic surgery,
R Gray, and P K Shah, and B Singh, and C Conklin, and J M Matloff
June 1983, Acta anaesthesiologica Scandinavica,
R Gray, and P K Shah, and B Singh, and C Conklin, and J M Matloff
October 2008, European journal of medical research,
R Gray, and P K Shah, and B Singh, and C Conklin, and J M Matloff
November 2007, European journal of medical research,
R Gray, and P K Shah, and B Singh, and C Conklin, and J M Matloff
January 1979, Giornale italiano di cardiologia,
R Gray, and P K Shah, and B Singh, and C Conklin, and J M Matloff
January 1989, Critical care medicine,
Copied contents to your clipboard!